Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats

Journal of Hypertension

Volumn 24, Issue 11, 2006, Pages 2215-2223

  Vettoretti, Simone ^a   Ochodnicky, Peter ^a   Buikema, Hendrik ^a   Henning, Rob H ^a   Kluppel, C Alex ^a   De Zeeuw, Dick ^a   Van Dokkum, Richard P E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Angiotensin converting enzyme inhibitors; Chronic renal failure; Endothelium; Endothelium derived hyperpolarizing factor; Hypertension; Myogenic constriction; Small mesenteric artery; Subtotal nephrectomy

Indexed keywords

ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; LISINOPRIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOGRAPHY; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; ENDOTHELIUM CELL; EVALUATION; HYPERTENSION; MALE; MESENTERIC ARTERY; MUSCLE DEVELOPMENT; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 33750239198     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000249699.04113.36     Document Type: Article

References (39)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42:1050-1065.
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5:2024-2031.
4. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 2002; 287:1548-1555.
5. Flack JM, Peters R, Shafi T, Alrefai H, Nasser SA, Crook E. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol 2003; 14:S92-S98.
6. Benchetrit S, Green J, Katz D, Bernheim J, Rathaus M. Early endothelial dysfunction following renal mass reduction in rats. Eur J Clin Invest 2003; 33:26-33.
7. Hasdan G, Benchetrit S, Rashid G, Green J, Bernheim J, Rathaus M. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int 2002; 61:586-590.
8. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci 2002; 23:374-380.
9. Gschwend S, Pinto-Sietsma SJ, Buikema H, Pinto YM, van Gilst WH, Schulz A, et al. Impaired coronary endothelial function in a rat model of spontaneous albuminuria. Kidney Int 2002; 62:181-191.
10. Lagaud GJ, Skarsgard PL, Laher I, van Breemen C. Heterogeneity of endothelium-dependent vasodilation in pressurized cerebral and small mesenteric resistance arteries of the rat. J Pharmacol Exp Ther 1999; 290:832-839.
11. Ochodnicky P, Henning RH, Provoost AP, de Zeeuw D, van Dokkum RP. Heterogeneity of systemic and renal endothelial dysfunction in a rat model of hypertension-associated renal damage [abstract]. J Am Soc Nephrol 2005; 16:185A.
12. Kohler R, Eichler I, Schonfelder H, Grgic I, Heinau P, Si H, Hoyer J. Impaired EDHF-mediated vasodilation and function of endothelial Ca-activated K channels in uremic rats. Kidney Int 2005; 67:2280-2287.
13. Kimura K, Nishio I. Impaired endothelium-dependent relaxation in mesenteric arteries of reduced renal mass hypertensive rats. Scand J Clin Lab Invest 1999; 59:199-204.
14. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999; 79:387-423.
15. Falcone JC, Granger HJ, Meininger GA. Enhanced myogenic activation in skeletal muscle arterioles from spontaneously hypertensive rats. Am J Physiol 1993; 265:H1847-H1855.
16. Huang A, Koller A. Endothelin and prostaglandin H2 enhance arteriolar myogenic tone in hypertension. Hypertension 1997; 30:1210-1215.
17. Shibuya J, Ohyanagi M, Iwasaki T. Enhanced myogenic response in resistance small arteries from spontaneously hypertensive rats: relationship to the voltage-dependent calcium channel. Am J Hypertens 1998; 11:767-773.
18. Ca channels. Hypertension 2003; 41:912-918.
19. Hughes JM, Bund SJ. Arterial myogenic properties of the spontaneously hypertensive rat. Exp Physiol 2002; 87:527-534.
20. Hostetter TH. Progression of renal disease and renal hypertrophy. Annu Rev Physiol 1995; 57:263-278.
21. Kim KE, Onesti G, Swartz CD. Hemodynamics of hypertension in uremia. Kidney Int Suppl 1975; 2:55-62.
22. New DI, Chesser AM, Raftery MJ, Yaqoob MM. The myogenic response in uremic hypertension. Kidney Int 2003; 63:642-646.
23. Kalliovalkama J, Jolma P, Tolvanen JP, Kahonen M, Hutri-Kahonen N, Saha H, et al. Potassium channel-mediated vasorelaxation is impaired in experimental renal failure. Am J Physiol Heart Circ Physiol 1999; 277:H1622-H1629.
24. Koobi P, Kalliovalkama J, Jolma P, Rysa J, Ruskoaho H, Vuolteenaho O, et al. AT1 receptor blockade improves vasorelaxation in experimental renal failure. Hypertension 2003; 41:1364-1371.
25. Fujii K, Tominaga M, Ohmori S, Kobayashi K, Koga T, Takata Y, Fujishima M. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res 1992; 70:660-669.
26. Wu X, Makynen H, Kahonen M, Arvola P, Porsti I. Mesenteric arterial function in vitro in three models of experimental hypertension. J Hypertens 1996; 14:365-372.
27. Sofola OA, Knill A, Hainsworth R, Drinkhill M. Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet. J Physiol 2002; 543:255-260.
28. Huang A, Sun D, Smith CJ, Connetta JA, Shesely EG, Koller A, Kaley G. In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF. Am J Physiol Heart Circ Physiol 2000; 278:H762-H768.
29. Corriu C, Feletou M, Puybasset L, Bea ML, Berdeaux A, Vanhoutte PM. Endothelium-dependent hyperpolarization in isolated arteries taken from animals treated with NO-synthase inhibitors. J Cardiovasc Pharmacol 1998; 32:944-950.
30. Kalliovalkama J, Jolma P, Tolvanen JP, Kahonen M, Hutri-Kahonen N, Wu X, et al. Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism. Cardiovasc Res 1999; 42:773-782.
31. Rump LC, Amann K, Orth S, Ritz E. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 2000; 15:1735-1738.
32. Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Circulation 2004; 109:1186-1193.
33. Gretz N, Waldherr R, Strauch M. The remnant kidney model. In: Gretz N, Strauch M, editors. Experimental and genetic models of chronic renal failure. Basel: Karger; 1993, pp. 1-23.
34. Meininger GA, Faber JE. Adrenergic facilitation of myogenic response in skeletal muscle arterioles. Am J Physiol Heart Circ Physiol 1991; 260:H1424-H1432.
35. Gschwend S, Henning RH, Pinto YM, de Zeeuw D, van Gilst WH, Buikema H. Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. Br J Pharmacol 2003; 139:1317-1325.
36. Nurkiewicz TR, Boegehold MA. Reinforcement of arteriolar myogenic activity by endogenous ANG II: susceptibility to dietary salt. Am J Physiol Heart Circ Physiol 2000; 279:H269-H278.
37. Ca-channel blockade prevents sustained pressure-induced depolarization in rat mesenteric small arteries. Am J Physiol Heart Circ Physiol 1997; 272:H2241-H2249.
38. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 1992; 256:532-535.
39. Minami K, Hirata Y, Tokumura A, Nakaya Y, Fukuzawa K. Protein kinase C-independent inhibition of the Ca(2)-activated K channel by angiotensin II and endothelin-1. Biochem Pharmacol 1995; 49:1051-1056.